The DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Open accessAbstract
Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Benzodiazepines are commonly prescribed for anxiety and insomnia but are often misused for their sedative effects [64, 65].”
From Prevalence and patterns of substance use in West Africa: A systematic review and meta-analysis (2024) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Neurobiologic advances from the brain disease model of addiction
Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1511480 · Cited by 2,008
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943 · cited 10×
“However, the study [21] acknowledged the difficulty prescribers face when they “inherit” patients who previously received BZDs from other prescribers (many of whom started BZDs prior to CPGs), creating “an immediate tension” as providers attempt to balance individual patient factors with the need to provide evidence-ba…”
BackgroundInfluentialSateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519 · cited 9×
“However, the study [21] acknowledged the difficulty prescribers face when they “inherit” patients who previously received BZDs from other prescribers (many of whom started BZDs prior to CPGs), creating “an immediate tension” as providers attempt to balance individual patient factors with the need to provide evidence-ba…”
BackgroundInfluentialOpioid-induced Hyperalgesia: A Qualitative Systematic Review
Angst, M. S., & Clark, J. D. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00025 · Cited by 1,188
Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature
Jacobsen, L. K., Southwick, S. M., & Kosten, T. R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1184 · Cited by 1,041 · cited 1×
“High rates of comorbidity suggest that PTSD and SUDs are functionally related, a concept supported by several studies indicating a pathway (likely related to corticotropin-releasing hormone and norepinephrine) whereby PTSD precedes substance use [69].”
BackgroundFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927 · cited 1×
“These “antidepressants” (that are not only effective for depression) typically take four to six weeks before they exert clinical effect, though in the treatment of anxiety symptoms this delay can be even longer [30].”
BackgroundComparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
Smith, M. T., Perlis, M. L., Park, A., Smith, M. S., Pennington, J., Giles, D. E., & Buysse, D. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.5 · Cited by 863 · cited 2×
“…SAD and insomnia, BZDs are frequently overprescribed for other indications for which there is no evidence of efficacy, to individuals who have contraindicated comorbid conditions, for longer periods of time than are recommended, and before other first and second-line treatments are tried [52–57].”
BackgroundBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Research works printed but not linked: 6
- Pary, 2008, Prescribing benzodiazepines in clinical practice, Resid. Staff Phys., 54, 8
- Stahl, S.M. (2013). Essential Psychopharmacology, Cambridge. [4th ed.].
- Powers, M., Becker, E., Gorman, J., Kissen, D., Smits, J., and Anxiety and Depression Association of America (2017, October 20). Clinical Practice Review for GAD. Available online: https:/adaa.org.
- Foa, E.B., Keane, T.M., Friedman, M.J., and Cohen, J.A. (2009). Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies, Guilford Press. [2nd ed.].
- Ader, R. (2006). Psychoneuroimmunology, Elsevier Academic Press.
- Tasman, 2008, Pharmacological issues during pregnancy, Psychiatry, Volume 1, 2423
Cited by
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 191
“GABAAR PAMs including benzodiazepines are used for treating epilepsy and forms of anxiety disorder 192 .”
Sumsuzzman, D. M., Choi, J., Jin, Y., & Hong, Y. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.034 · Cited by 144
Massoudi, B., Holvast, F., Bockting, C. L. H., Burger, H., & Blanker, M. H. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.050 · Cited by 101
Detyniecki, K., Ess, P. J. V., Sequeira, D. J., Wheless, J. W., Meng, T., & Pullman, W. E. (2019) · Epilepsia · doi:10.1111/epi.15159 · Cited by 112
Metadata
- Authors
- Guina, J., & Merrill, B.
- Affiliations
- Wright State University (US)
- Corresponding author
- Guina, Jeffrey
- ORCID
- Guina, Jeffrey
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-01-30
- Volume
- 7
- Issue
- 2
- Pages
- 17
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5852433
- OpenAlex
- W2793017265
- Semantic Scholar
- 81e4137cd04cbc40756500350418397c8843db63
- Cited by
- 253
- References
- 99
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 34 · 2023: 42 · 2022: 32 · 2021: 42 · 2020: 34 · 2019: 25 · 2018: 6
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Journal of Bioresource Management (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepines, sedative-hypnotic drugs, anxiety, insomnia, adverse effects, drug-drug interactions, long-term benzodiazepine use, psychotherapy, sleep hygiene, serotonergic agents, functional recovery, biopsychosocial model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. https://app.cochat.ai/papers/10.3390/jcm7020017
- The paper
- Guina, J., & Merrill, B. (2018). Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7020017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.